FDA Device recall Z-0947-2022
Matrix Clinical Solution At-Home COVID-19 Test
- FDA Device
- Class II
- ongoing
- Published 2022-04-27
On 2022-04-27 the FDA classified a Class II recall of Matrix Clinical Solution At-Home COVID-19 Test by Matrix Medical Network, citing due to COVID-19 Test not being authorized for home sample collection.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0947-2022 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2022-01-24 |
| Published | 2022-04-27 |
| Last updated | 2026-09-13 11:56 UTC |
| Company | Matrix Medical Network |
| Distribution | AL, AZ, CA, CO, CT, DC, DE, FL, GA, LA, MA, MD, MI, MN, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, WV |
Product
Matrix Clinical Solution At-Home COVID-19 Test
Reason
Due to COVID-19 Test not being authorized for home sample collection.
Identifiers
| code_info | Product Number SKU: 15206 All Test Kits No Lot Numbers |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0947-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.